Emergence of CA125-positive tumour cells was noted in all carboplatin-treated xenografts after therapy was stopped, demonstrating in vivo differentiation of the CA125-negative population after cessation of treatment (Supplementary Fig. 8d). Here, MUC16 is linked to neoplasm.